Emicizumab (Hemlibra)

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search

Mechanism of action

A recombinant, humanized, bispecific monoclonal antibody that bridges activated factor IX and factor X to restore the function of missing activated factor VIII.

Diseases for which it is used

History of changes in FDA indication

Also known as

  • Code name: ACE910
  • Generic name: emicizumab-kxwh
  • Brand name: Hemlibra